Marjon H. Cnossen

4.4k total citations
178 papers, 2.6k citations indexed

About

Marjon H. Cnossen is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Marjon H. Cnossen has authored 178 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Hematology, 62 papers in Genetics and 19 papers in Surgery. Recurrent topics in Marjon H. Cnossen's work include Hemophilia Treatment and Research (93 papers), Platelet Disorders and Treatments (87 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Marjon H. Cnossen is often cited by papers focused on Hemophilia Treatment and Research (93 papers), Platelet Disorders and Treatments (87 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Marjon H. Cnossen collaborates with scholars based in Netherlands, United Kingdom and United States. Marjon H. Cnossen's co-authors include Frank W.G. Leebeek, Karin Fijnvandraat, Karina Meijer, Ron A. A. Mathôt, Johanna G. van der Bom, Britta A. P. Laros‐van Gorkom, Jeroen Eikenboom, Marjolein Peters, Inge M. Appel and Arja de Goede-Bolder and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Marjon H. Cnossen

164 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjon H. Cnossen Netherlands 30 1.8k 685 321 272 259 178 2.6k
Jørgen Ingerslev Denmark 30 2.3k 1.3× 432 0.6× 144 0.4× 385 1.4× 137 0.5× 94 3.4k
Tobias Wirenfeldt Klausen Denmark 32 1.1k 0.6× 436 0.6× 107 0.3× 432 1.6× 227 0.9× 143 3.3k
Caterina P. Minniti United States 35 1.6k 0.9× 2.1k 3.0× 111 0.3× 211 0.8× 118 0.5× 158 3.4k
Lothar Huebsch Canada 21 674 0.4× 182 0.3× 132 0.4× 159 0.6× 180 0.7× 73 1.5k
F.R. Rosendaal Netherlands 26 1.1k 0.6× 285 0.4× 60 0.2× 332 1.2× 182 0.7× 56 2.3k
Martine Alhenc‐Gelas France 32 1.7k 1.0× 410 0.6× 46 0.1× 529 1.9× 129 0.5× 118 3.1k
Jedrzej Hoffmann Germany 26 544 0.3× 434 0.6× 822 2.6× 309 1.1× 238 0.9× 51 3.3k
Amparo Vayá Spain 29 869 0.5× 215 0.3× 82 0.3× 400 1.5× 423 1.6× 156 2.9k
H. H. Kuper Netherlands 14 1.9k 1.1× 756 1.1× 155 0.5× 283 1.0× 239 0.9× 16 6.0k
Dianne Gallagher United States 19 1.4k 0.8× 1.7k 2.5× 38 0.1× 92 0.3× 305 1.2× 24 2.1k

Countries citing papers authored by Marjon H. Cnossen

Since Specialization
Citations

This map shows the geographic impact of Marjon H. Cnossen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjon H. Cnossen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjon H. Cnossen more than expected).

Fields of papers citing papers by Marjon H. Cnossen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjon H. Cnossen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjon H. Cnossen. The network helps show where Marjon H. Cnossen may publish in the future.

Co-authorship network of co-authors of Marjon H. Cnossen

This figure shows the co-authorship network connecting the top 25 collaborators of Marjon H. Cnossen. A scholar is included among the top collaborators of Marjon H. Cnossen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjon H. Cnossen. Marjon H. Cnossen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henskens, Yvonne, Maartje van den Biggelaar, Roger E. G. Schutgens, et al.. (2025). Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National Survey. Haemophilia. 31(4). 752–760.
2.
Pastoor, Hester, Jeroen Eikenboom, Karin Fijnvandraat, et al.. (2025). Sexuality and bleeding in von Willebrand disease. Research and Practice in Thrombosis and Haemostasis. 9(2). 102712–102712.
3.
4.
Rab, Minke A.E., Brigitte A. van Oirschot, Anita W. Rijneveld, et al.. (2024). Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease. HemaSphere. 8(6). e109–e109. 1 indexed citations
5.
Atiq, Ferdows, Karin Fijnvandraat, Karin P. M. van Galen, et al.. (2024). Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study. Journal of Thrombosis and Haemostasis. 22(12). 3460–3472. 2 indexed citations
6.
Teela, Lorynn, Martijn A. H. Oude Voshaar, Idske C. L. Kremer Hovinga, et al.. (2024). Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders. Research and Practice in Thrombosis and Haemostasis. 8(4). 102474–102474. 3 indexed citations
7.
Simons, Annet, Marjan M. Weiss, Sanna R. Rijpma, et al.. (2024). Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study. Research and Practice in Thrombosis and Haemostasis. 8(4). 102477–102477. 4 indexed citations
8.
Teela, Lorynn, Michiel A. J. Luijten, Samantha C. Gouw, et al.. (2023). Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banks. Research and Practice in Thrombosis and Haemostasis. 7(6). 102159–102159. 3 indexed citations
9.
Rab, Minke A.E., Brigitte A. van Oirschot, Anita W. Rijneveld, et al.. (2023). One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study. Blood Advances. 7(24). 7539–7550. 8 indexed citations
10.
Meijer, Karina, et al.. (2023). Ethical aspects of hemophilia gene therapy: a qualitative interview study with stakeholders. Research and Practice in Thrombosis and Haemostasis. 7(7). 102237–102237. 2 indexed citations
11.
Janßen, Alexander, et al.. (2023). ChatGPT in pharmacometrics? Potential opportunities and limitations. British Journal of Clinical Pharmacology. 90(1). 360–365. 17 indexed citations
12.
Bagot, Catherine, Erik A.M. Beckers, Giancarlo Castaman, et al.. (2022). The bleeding phenotype in people with nonsevere hemophilia. Blood Advances. 6(14). 4256–4265. 17 indexed citations
13.
Coppens, Michiel, Saskia E.M. Schols, Roger E. G. Schutgens, et al.. (2022). Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study). SHILAP Revista de lepidopterología. 6(1). e60–e69. 2 indexed citations
14.
Atiq, Ferdows, Johan Boender, Waander L. van Heerde, et al.. (2022). Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease. Blood Advances. 6(18). 5317–5326. 9 indexed citations
15.
Fijnvandraat, Karin, Karina Meijer, Jeroen Eikenboom, et al.. (2021). Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease. Blood Advances. 5(5). 1513–1522. 9 indexed citations
16.
Romano, Lorenzo, et al.. (2021). Outcome of Surgical Interventions and Deliveries in Patients with Bleeding of Unknown Cause: An Observational Study. Thrombosis and Haemostasis. 121(11). 1409–1416. 12 indexed citations
17.
Kitchen, Steve, Piet Meijer, Marjon H. Cnossen, et al.. (2020). Performance of factor IX extended half‐life product measurements in external quality control assessment programs. Journal of Thrombosis and Haemostasis. 18(8). 1874–1883. 13 indexed citations
18.
Schutgens, Roger E. G., Britta A. P. Laros‐van Gorkom, Laurens Nieuwenhuizen, et al.. (2020). von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients. Thrombosis and Haemostasis. 120(7). 1056–1065. 5 indexed citations
19.
Atiq, Ferdows, Karina Meijer, Jeroen Eikenboom, et al.. (2018). Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease. British Journal of Haematology. 182(1). 93–105. 34 indexed citations
20.
Václavů, Lena, Dennis Heijtel, Matthias J.P. van Osch, et al.. (2016). In Vivo T1 of Blood Measurements in Children with Sickle Cell Disease Improve Cerebral Blood Flow Quantification from Arterial Spin-Labeling MRI. American Journal of Neuroradiology. 37(9). 1727–1732. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jørgen Ingerslev Breakdown of academic impact, for papers by Tobias Wirenfeldt Klausen Breakdown of academic impact, for papers by Caterina P. Minniti Breakdown of academic impact, for papers by Lothar Huebsch Breakdown of academic impact, for papers by F.R. Rosendaal Breakdown of academic impact, for papers by Martine Alhenc‐Gelas Breakdown of academic impact, for papers by Jedrzej Hoffmann Breakdown of academic impact, for papers by Amparo Vayá Breakdown of academic impact, for papers by H. H. Kuper Breakdown of academic impact, for papers by Dianne Gallagher
Rankless by CCL
2026